Aoxing Pharmaceutical Company, Inc. (AOXG)
OTCMKTS
· Delayed Price · Currency is USD
0.0072
-0.0013 (-15.29%)
Jan 21, 2025, 3:00 PM EST
AOXG Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | 2011 - 2007 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '17 Mar 31, 2017 | Jun '16 Jun 30, 2016 | Jun '15 Jun 30, 2015 | Jun '14 Jun 30, 2014 | Jun '13 Jun 30, 2013 | Jun '12 Jun 30, 2012 | 2011 - 2007 |
Cash & Equivalents | 7.08 | 6.91 | 5.37 | 2.33 | 4.01 | 3.68 | Upgrade
|
Cash & Short-Term Investments | 7.08 | 6.91 | 5.37 | 2.33 | 4.01 | 3.68 | Upgrade
|
Cash Growth | 17.10% | 28.68% | 130.57% | -41.87% | 8.83% | 32.92% | Upgrade
|
Receivables | 15.29 | 11.2 | 5.85 | 3.89 | 2.84 | 2.8 | Upgrade
|
Inventory | 2.41 | 2.84 | 3.24 | 2.2 | 2.62 | 1.81 | Upgrade
|
Prepaid Expenses | 10.03 | 5.91 | 6.63 | 2.51 | 2.42 | 1.23 | Upgrade
|
Total Current Assets | 34.8 | 26.87 | 21.1 | 10.92 | 11.89 | 9.52 | Upgrade
|
Property, Plant & Equipment | 24.04 | 25.6 | 28.65 | 26.42 | 26.94 | 26.96 | Upgrade
|
Long-Term Investments | - | 0 | 0.1 | 0.19 | 0.29 | 0.4 | Upgrade
|
Goodwill | - | - | - | - | - | 6.91 | Upgrade
|
Other Intangible Assets | 1.8 | 1.88 | 0.48 | 0.55 | 0.61 | 1.3 | Upgrade
|
Long-Term Deferred Tax Assets | 1.83 | 1.88 | 2.71 | - | - | - | Upgrade
|
Total Assets | 62.47 | 56.23 | 53.04 | 38.07 | 39.73 | 45.09 | Upgrade
|
Accounts Payable | 4.24 | 2.71 | 5.26 | 3.88 | 3.41 | 2.76 | Upgrade
|
Accrued Expenses | 7.85 | 6.01 | 5.03 | 2.39 | 2.5 | 2.08 | Upgrade
|
Short-Term Debt | 27.62 | 25.44 | 28.8 | 14.65 | 6.54 | 3.24 | Upgrade
|
Current Portion of Long-Term Debt | - | 0.03 | 0.01 | 11.25 | 7.34 | 9.03 | Upgrade
|
Current Income Taxes Payable | 3.45 | 2.62 | 1.28 | 0.42 | 0.26 | 0.21 | Upgrade
|
Current Unearned Revenue | 0.26 | 0.41 | 0.29 | 0.73 | - | - | Upgrade
|
Other Current Liabilities | 0.55 | 0.59 | 0.57 | 0.89 | 1.66 | 1.31 | Upgrade
|
Total Current Liabilities | 43.97 | 37.82 | 41.24 | 34.21 | 21.7 | 18.63 | Upgrade
|
Long-Term Debt | 0.1 | - | 1.37 | 7.5 | 13.08 | 5.19 | Upgrade
|
Long-Term Unearned Revenue | 0.31 | 0.34 | 0.37 | 0.37 | 0.37 | - | Upgrade
|
Total Liabilities | 44.38 | 38.16 | 42.98 | 42.08 | 35.15 | 23.82 | Upgrade
|
Common Stock | 0.08 | 0.08 | 0.07 | 0.05 | 0.05 | 0.05 | Upgrade
|
Additional Paid-In Capital | 73.65 | 73.63 | 66.46 | 58.32 | 58.3 | 58 | Upgrade
|
Retained Earnings | -55.86 | -56.29 | -58.35 | -63.85 | -55.63 | -38.83 | Upgrade
|
Comprehensive Income & Other | 1.24 | 1.72 | 3.07 | 2.98 | 2.96 | 2.66 | Upgrade
|
Total Common Equity | 19.11 | 19.14 | 11.24 | -2.51 | 5.67 | 21.88 | Upgrade
|
Minority Interest | -1.02 | -1.06 | -1.18 | -1.5 | -1.09 | -0.62 | Upgrade
|
Shareholders' Equity | 18.09 | 18.08 | 10.06 | -4.01 | 4.58 | 21.27 | Upgrade
|
Total Liabilities & Equity | 62.47 | 56.23 | 53.04 | 38.07 | 39.73 | 45.09 | Upgrade
|
Total Debt | 27.72 | 25.47 | 30.18 | 33.4 | 26.96 | 17.47 | Upgrade
|
Net Cash (Debt) | -20.64 | -18.56 | -24.8 | -31.07 | -22.96 | -13.78 | Upgrade
|
Net Cash Per Share | -0.27 | -0.25 | -0.39 | -0.62 | -0.46 | -0.28 | Upgrade
|
Filing Date Shares Outstanding | 76.21 | 76.21 | 69.84 | 49.87 | 49.81 | 49.62 | Upgrade
|
Total Common Shares Outstanding | 76.21 | 76.21 | 69.84 | 49.87 | 49.81 | 49.62 | Upgrade
|
Working Capital | -9.17 | -10.95 | -20.14 | -23.29 | -9.81 | -9.11 | Upgrade
|
Book Value Per Share | 0.25 | 0.25 | 0.16 | -0.05 | 0.11 | 0.44 | Upgrade
|
Tangible Book Value | 17.31 | 17.26 | 10.75 | -3.05 | 5.06 | 13.67 | Upgrade
|
Tangible Book Value Per Share | 0.23 | 0.23 | 0.15 | -0.06 | 0.10 | 0.28 | Upgrade
|
Land | - | 7.53 | 8.16 | 8.12 | 8.08 | 7.91 | Upgrade
|
Buildings | - | 20.29 | 19.39 | 19.3 | 13.51 | 13.23 | Upgrade
|
Machinery | - | 4.71 | 7.66 | 5.12 | 4.98 | 4.67 | Upgrade
|
Construction In Progress | - | 0.49 | 0.46 | 0.27 | 5.79 | 5.45 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.